1μg (R: reducing condition, N: non-reducing condition).
Product Details
Product Details
Product Specification
Species | Human |
Synonyms | NTB-A, SLAMF6, Ly108, NK-T-B-antigen, CD352, KALI |
Accession | Q96DU3-1 |
Amino Acid Sequence | Gln22-Met226, with C-terminal Fc |
Expression System | HEK293 |
Molecular Weight | 60-72kDa (Reducing) |
Purity | >95% by SDS-PAGE |
Endotoxin | <0.1EU/μg |
Conjugation | Unconjugated |
Tag | Human Fc Tag |
Physical Appearance | Lyophilized Powder |
Storage Buffer | PBS, pH7.4. |
Reconstitution | Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation. |
Stability & Storage | · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃. · 3 months, -20 to -80℃ under sterile conditions after reconstitution. · 1 week, 2 to 8℃ under sterile conditions after reconstitution. · Please avoid repeated freeze-thaw cycles. |
Reference | Veillette, A. (2006) Immunol. Rev. 214:22. Bottino, C. et al. (2001) J. Exp. Med. 194:235. Fraser, C.C. et al. (2002) Immunogenetics 53:843. Eissmann, P. and C. Watzl (2006) J. Immunol. 177:3170. |
Background
NTB-A (NK-T-B-antigen), also known as Ly108 and SLAMF6, is a 60 kDa type I transmembrane glycoprotein that belongs to the SLAM subgroup of the CD2 family. Mature human NTB-A contains a 205 amino acid (aa) extracellular domain (ECD) with one Ig-like V-set and one Ig-like C2-set domain. It also contains a 21 aa transmembrane segment and an 84 aa cytoplasmic domain with two immunoreceptor tyrosine-based switch motifs (ITSMs). An alternately spliced isoform is truncated in the cytoplasmic domain and lacks the two ITSMs. NTB-A functions as an activating coreceptor on NK and T cells. Tyrosine phosphorylation in the membrane proximal ITSM enables specific association with EAT-2, an interaction that is required for NTB-A mediated cytotoxicity of NK cells.
Picture
Picture
SDS-PAGE
SEC-HPLC
